Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,440 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07892196Recruiting
How chronic pain changes over time in children with Duchenne muscular dystrophy
This study follows children with Duchenne muscular dystrophy for 6 months to see how their chronic pain changes over time. It aims to understand pain patterns better so that treatments can be improved.
Antalya, AntalyaAges 7–18 - NCT07746141RecruitingPhase 1
Study of BG-85738 for advanced solid tumors with RAS mutations
This trial is testing a new drug called BG-85738, which may target cancer cells that have a specific change (mutation) in the RAS gene. The goal is to see if it is safe and works against advanced or spreading solid tumors.
South Brisbane, QueenslandAges 18 years+ - NCT07585266RecruitingPhase 3
New drug velzatinib versus imatinib for untreated GIST
This trial compares a newer cancer drug (velzatinib) with a standard treatment (imatinib) for gastrointestinal stromal tumors (GIST) that cannot be surgically removed or have spread. You would receive one of these two drugs to see which works better and is safer.
Scottsdale, ArizonaAges 18 years+ - NCT07853131RecruitingPhase 1
How rilzabrutinib tablet is processed in people with severe kidney disease
This study looks at how a medicine called rilzabrutinib (taken as a tablet) is processed in the body when the kidneys are severely damaged compared to when they work normally. It helps researchers understand if the dose needs to be adjusted for people with kidney problems.
Hialeah, FloridaAges 18–75 - NCT07428616RecruitingPhase 2
Study of Zanzalintinib for recurring meningioma
This trial tests a drug called Zanzalintinib for people with meningioma that has come back or grown despite past treatments. It aims to see if the drug can stop or slow tumor growth.
Birmingham, AlabamaAges 18 years+ - NCT06302348RecruitingPhase 3
Sepiapterin study for phenylketonuria
This study tests a new medicine called sepiapterin to see if it can help control blood phenylalanine levels in people with PKU. The trial aims to find a safe and effective dose for different age groups.
Indianapolis, IndianaAges Up to 9 years - NCT07099053Recruiting
Brain scan study for aging adults in Baltimore
This study uses a special brain scan (amyloid PET) to look at brain changes in healthy older adults. It may help researchers learn more about aging and memory loss.
Baltimore, MarylandAges 55–110 - NCT06090539RecruitingPhase 1/Phase 2
New drug for lymphoma that has returned or not responded
This trial tests a new drug, BMS-986458, alone or with other lymphoma treatments, for people with non-Hodgkin lymphoma that has come back or not gotten better after prior treatment.
Phoenix, ArizonaAges 18 years+ - NCT06987539RecruitingPhase 2
Inebilizumab for children with generalized myasthenia gravis
This study tests a new drug called inebilizumab for children with generalized myasthenia gravis (gMG), a condition causing muscle weakness. The drug aims to reduce the immune system's attack on nerves, which may improve symptoms. The study will check how safe and effective it is for young patients.
Chicago, IllinoisAges 2–17 - NCT07874620RecruitingPhase 2
Study of cebranopadol for opioid withdrawal in chronic pain
This trial tests a new medicine, cebranopadol, to help reduce withdrawal symptoms when people with chronic pain stop or reduce their opioid painkillers. It may help make the withdrawal process more comfortable and manageable.
North Canton, OhioAges 18–65 - NCT07694440RecruitingPhase 2
Study of an experimental pill for adults with PKU
This trial tests an experimental medication taken as a pill to see if it can help people with PKU manage their condition. The study will check if the pill is safe and how it affects blood phenylalanine levels.
Oakland, CaliforniaAges 18–75 - NCT07700758RecruitingPhase 2
Belzutifan for teenagers with solid tumors
This study tests an oral drug called belzutifan in teenagers with certain solid tumors. Belzutifan may shrink tumors by blocking a protein that helps them grow.
Iowa City, IowaAges 12–17 - NCT07020221RecruitingPhase 1/Phase 2
Study of VS-7375 for cancers with a KRAS G12D mutation
This study tests an experimental drug called VS-7375 for people with advanced solid tumors that have a specific genetic change called KRAS G12D. The goal is to see if the drug can shrink tumors or slow their growth.
Los Angeles, CaliforniaAges 18 years+ - NCT07807345RecruitingPhase 1
STRO-006 for advanced solid tumors that have resisted treatment
This study tests an experimental drug called STRO-006 in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective for cancers like head and neck, lung, stomach, colorectal, endometrial, bladder, and breast cancer.
Orlando, FloridaAges 18 years+ - NCT05675410RecruitingPhase 3
Testing two-drug treatment versus standard for Hodgkin lymphoma
This Phase 3 study compares today’s standard treatment for classic Hodgkin lymphoma with a new combination using brentuximab vedotin and nivolumab. The goal is to see which approach works better and is safe for newly diagnosed patients with early-stage disease.
Birmingham, AlabamaAges 5–60 - NCT07769307Recruiting
Adjusting ventilator support based on breathing effort
This trial is testing a new way to adjust the pressure support (the extra help you get when breathing on the ventilator) based on your own breathing effort. It aims to make weaning off the ventilator safer and more effective for people who need it for more than 48 hours.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07246330RecruitingPhase 3
Continued immunotherapy after chemoradiation for advanced esophageal cancer
This trial tests whether continuing a type of immunotherapy (toripalimab) after standard chemoradiation helps keep advanced esophageal cancer from growing, compared to just watching and waiting. If you've already completed initial treatment without the cancer getting worse, this study might help you stay stable longer.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT07184996RecruitingPhase 3
Study of duvakitug for moderate to severe ulcerative colitis
This study tests a new drug called duvakitug for people with moderate to severe ulcerative colitis that hasn't been helped enough by standard treatments. The goal is to see if this medicine can reduce inflammation and improve symptoms.
Peoria, ArizonaAges 16–80 - NCT05987241RecruitingPhase 2/Phase 3
Using a blood test to guide immunotherapy after bladder/kidney cancer surgery
This study tests whether a blood test that detects tumor DNA can help guide the use of immunotherapy (nivolumab with or without relatlimab) after surgery for urothelial cancer. The goal is to see if starting immunotherapy based on the blood test results can prevent the cancer from coming back.
Phoenix, ArizonaAges 18 years+ - NCT07361510RecruitingPhase 3
Pumitamig vs Keytruda for advanced lung cancer with high PD-L1
This trial compares an experimental drug called Pumitamig with the approved immunotherapy drug Pembrolizumab (Keytruda) as the first treatment for advanced lung cancer that has high PD-L1 levels. The goal is to see which drug works better and has fewer side effects.
Daphne, AlabamaAges 18 years+ - NCT07421713Recruiting
AI and chest x-rays to screen for osteoporosis
This trial tests if an AI software can use a chest x-ray to screen for osteoporosis, compared to the standard DXA bone density scan. It may offer a faster, simpler way to check bone health in people 50 and older.
Rotterdam, NetherlandsAges 50 years+ - NCT07215858RecruitingPhase 2
Testing a new flu vaccine against H1N1 flu
This study tests an experimental flu vaccine (BPL-1357) in healthy volunteers who will later be exposed to H1N1 flu virus in a controlled setting, to see if the vaccine can prevent or reduce illness.
Bethesda, MarylandAges 18–55 - NCT07453602RecruitingPhase 1
Study of ARQ-234 for healthy adults and those with atopic dermatitis
This trial tests a new medication called ARQ-234 in healthy adults and people with moderate-to-severe atopic dermatitis (eczema). The study looks at how the body handles single and multiple doses, and if it can help treat eczema.
Miami, FloridaAges 18–65 - NCT07633158Recruiting
Real-world study of tezepelumab for chronic nasal polyps
This study follows patients with chronic rhinosinusitis with nasal polyps (CRSwNP)—a condition causing blocked sinuses and nasal growths—who are starting a new biologic medication called tezepelumab. Researchers will track how symptoms and quality of life improve over time in everyday medical practice.
BerlinAges 18–130
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,440 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.